Transparency Market Research states that the global bioreactors and
fermenters market, pegged at US$1,779.1 mn in 2016, will reach
US$4,461.0 mn by 2024 at a CAGR of 12.2% from 2016 to 2024.
On the basis of product type, the market has been segmented into
single-use and multi-use. Of these, the segment of multi-use
bioreactors presently accounts for the dominant share in the global
market. However, the segment of single-use bioreactors is expected to
register growth at a more promising pace, nearly 13% CAGR, as
compared to the multi-use segment over the forecast period.
Single-use bioreactors are finding increased demand owing to benefits
such as quick assembly lower capital expenditure, and smaller
footprint, and are expected to gain traction owing to the significant
rise in demand from developed countries and new start-up biotech
companies.
From a geographical standpoint, North America is anticipated to be
the leading regional market for bioreactors and fermenters in terms
of revenue contribution to the global market, chiefly owing to the
presence of leading bioprocessing manufacturers and the rising demand
for biologics. However, the Asia Pacific market is anticipated to be
the leading regional market in terms of growth rate over the forecast
period. The Asia Pacific bioreactors and fermenters market is
projected to record a commendable 14.3% CAGR from 2016 to 2024, owing
to the emergence of strong local players in countries such as India
and China.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15230
The leading factors to have boosted the global demand for bioreactors
and fermenters in the past few years include the increased adoption
of hybrid technologies, which use single-use and stainless steel
systems, and the increasing popularity of single-use disposable
bioreactors among biopharmaceutical companies and contract
manufacturers. The market is also driven due to the rising prevalence
of a number of chronic diseases, which has consecutively increased
the world’s appetite for biologics, drugs for orphan diseases, and
personalized medicines. These factors are expected to remain at the
helm of all major developments expected to be observed in the global
market for bioreactors and fermenters in the next few years.
On the contrary, factors such as the high cost associated with the
setting up of bioreactors and fermenters and the several concerns
associated with the rising use of single-use bioreactors are expected
to hamper the growth prospects of the market over the forecast
period. Although single-use bioreactors play a huge role in
mitigating issues such as cross-contamination that are generally
associated with multi-use bioreactors, they present concerns such as
the possible reaction of biologics with extractables and leachables
that can release from the material used to manufacture bioreactors.
Request a Brochure of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15230
The global market for bioreactors and fermenters features a largely
consolidated vendor landscape and a low to moderate level of
competition, with the top five companies accounting for a more than
63% of the overall market in 2015, observes Transparency Market
Research (TMR) in a recent report. These leading vendors, including
Thermo Fisher Scientific Inc., Merck KGaA, and Danaher Corporation,
dominate the market owing to their diversified product portfolios,
expansive presence across the globe, and an eye for high-growth
potential emerging markets, such as Asia Pacific, for expansion
strategies.
An instance of this would be Merck KGaA’s decision to enter the
Asian market by establishing a new pharmaceutical production plant in
China. Furthermore, another leading vendor in the global bioreactors
and fermenter market, Applikon Biotechnology, started a new
production facility in Guangzhou, China, in March 2014. The new
facility is expected to be able to provide a broad range of
bioreactor systems, help in reducing the lead time, and significantly
improve the local technical support for its customers in the China
market.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=15230
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment